Cargando…
Serum Midkine is a clinical significant biomarker for colorectal cancer and associated with poor survival
Colorectal carcinoma (CRC) is one of the most common carcinomas worldwide. Early detection is crucial for reducing morbidity and mortality. Several promising studies described the use of midkine (MK) as a tumor marker. This study aimed to investigate a larger collective to ascertain if the preoperat...
Autores principales: | Kemper, Marius, Hentschel, Wiebke, Graß, Julia‐Kristin, Stüben, Bjoern‐Ole, Konczalla, Leonie, Rawnaq, Tamina, Ghadban, Tarik, Izbicki, Jakob R., Reeh, Matthias |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7064087/ https://www.ncbi.nlm.nih.gov/pubmed/31984657 http://dx.doi.org/10.1002/cam4.2884 |
Ejemplares similares
-
Serum midkine as non-invasive biomarker for detection and prognosis of non-small cell lung cancer
por: Stern, Louisa, et al.
Publicado: (2021) -
Completion of FLOT Therapy, Regardless of Tumor Regression, Significantly Improves Overall Survival in Patients with Esophageal Adenocarcinoma
por: Stüben, Björn-Ole, et al.
Publicado: (2022) -
Clinical Significance of Circulating Tumor Cells in Gastrointestinal Carcinomas
por: Konczalla, Leonie, et al.
Publicado: (2020) -
CD147 expression lacks prognostic relevance in esophageal cancer
por: Küsters, Natalie, et al.
Publicado: (2022) -
Clinical Relevance of Circulating Tumor Cells in Esophageal Cancer Detected by a Combined MACS Enrichment Method
por: Woestemeier, Anna, et al.
Publicado: (2020)